Emerging Roles of CircRNAs in Leukemia and the Clinical Prospects: An Update

Overview

Journal Immun Inflamm Dis

Specialties Allergy & Immunology
Infectious Diseases

Date 2023 Jan 27

PMID 36705414

Authors

Wei Deng

Rong Chao

Shengdong Zhu

Affiliations

Soon will be listed here.

Abstract

Background: Circular RNAs (circRNAs) are a new category of endogenous non-protein coding RNAs (ncRNAs), and show the characteristics of high conservation, stability, and tissue specificity. Due to rapid advances in next-generation sequencing and transcriptome profiling technologies, circRNAs have been widely discovered in many organisms and participated in the development and progress of a variety of diseases. As a type of molecular sponge, circRNAs mainly absorb micro RNAs competitively and interplay with RNA-binding proteins to modulate the splicing as well as transcription of target genes.

Methods: This review is based on a literature search using the Medline database. Search terms used were "circular RNAs and leukemia," "circRNAs and leukemia," "circRNAs and acute lymphoblastic leukemia," "circRNAs and chronic lymphoblastic leukemia," "circRNAs and acute myeloid leukemia," "circRNAs and chronic myeloid leukemia," and "circRNAs, biomarker, and hematological system."

Results: CircRNAs have been proven as potential biomarkers and therapeutic targets in a variety of tumors. Recent research has found that circRNAs aberrantly exist in hematological cancers, especially leukemia, and are significantly associated with the incidence, progress, and metastasis of diseases as well as the prognosis of patients.

Conclusion: The current work summarizes the latest findings on circRNAs in various types of leukemia, aiming to propose prospective therapies and new drug screening methods for the treatment of leukemia.

Citing Articles

Potential Use of Exosomal Non-Coding MicroRNAs in Leukemia Therapy: A Systematic Review.

Gil-Kulik P, Kluz N, Przywara D, Petniak A, Wasilewska M, Fraczek-Chudzik N Cancers (Basel). 2024; 16(23).

PMID: 39682135 PMC: 11639955. DOI: 10.3390/cancers16233948.

MiR-133 promotes the multidrug resistance of acute myeloid leukemia cells (HL-60/ADR) to daunorubicin.

Liu L, Yu K, Yu J, Tao W, Wei Y Cytotechnology. 2024; 76(6):833-846.

PMID: 39435426 PMC: 11490624. DOI: 10.1007/s10616-024-00656-9.

Hsa_circ_0006010 and hsa_circ_0002903 in peripheral blood serve as novel diagnostic, surveillance and prognostic biomarkers for disease progression in chronic myeloid leukemia.

Zhao J, Wang G, Yan G, Zheng M, Li H, Bai Y BMC Cancer. 2024; 24(1):1172.

PMID: 39304860 PMC: 11414102. DOI: 10.1186/s12885-024-12943-x.

CircRNA: a rising star in leukemia.

Li Q, Ren X, Wang Y, Xin X PeerJ. 2023; 11:e15577.

PMID: 37431465 PMC: 10329819. DOI: 10.7717/peerj.15577.

Emerging roles of circRNAs in leukemia and the clinical prospects: An update.

Deng W, Chao R, Zhu S Immun Inflamm Dis. 2023; 11(1):e725.

PMID: 36705414 PMC: 9801069. DOI: 10.1002/iid3.725.

References

Tang B, Sun B, Chen L, Xiao J, Huang S, Xu P . The Landscape of Exosome-Derived Non-Coding RNA in Leukemia. Front Pharmacol. 2022; 13:912303. PMC: 9240230. DOI: 10.3389/fphar.2022.912303. View

Suguna E, Farhana R, Kanimozhi E, Kumar P, Kumaramanickavel G, Kumar C . Acute Myeloid Leukemia: Diagnosis and Management Based on Current Molecular Genetics Approach. Cardiovasc Hematol Disord Drug Targets. 2018; 18(3):199-207. DOI: 10.2174/1871529X18666180515130136. View

Buratin A, Paganin M, Gaffo E, Molin A, Roels J, Germano G . Large-scale circular RNA deregulation in T-ALL: unlocking unique ectopic expression of molecular subtypes. Blood Adv. 2020; 4(23):5902-5914. PMC: 7724907. DOI: 10.1182/bloodadvances.2020002337. View

Hallek M, Al-Sawaf O . Chronic lymphocytic leukemia: 2022 update on diagnostic and therapeutic procedures. Am J Hematol. 2021; 96(12):1679-1705. DOI: 10.1002/ajh.26367. View

Ren R . Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia. Nat Rev Cancer. 2005; 5(3):172-83. DOI: 10.1038/nrc1567. View

Khwaja A, Bjorkholm M, Gale R, Levine R, Jordan C, Ehninger G . Acute myeloid leukaemia. Nat Rev Dis Primers. 2016; 2:16010. DOI: 10.1038/nrdp.2016.10. View

Tao M, Zheng M, Xu Y, Ma S, Zhang W, Ju S . CircRNAs and their regulatory roles in cancers. Mol Med. 2021; 27(1):94. PMC: 8393742. DOI: 10.1186/s10020-021-00359-3. View

Wu Z, Sun H, Liu W, Zhu H, Fu J, Yang C . Circ-RPL15: a plasma circular RNA as novel oncogenic driver to promote progression of chronic lymphocytic leukemia. Leukemia. 2019; 34(3):919-923. DOI: 10.1038/s41375-019-0594-6. View

Ji T, Chen Q, Tao S, Shi Y, Chen Y, Shen L . The research progress of circular RNAs in hematological malignancies. Hematology. 2019; 24(1):727-731. DOI: 10.1080/16078454.2019.1669924. View

10.

Alhasan A, Izuogu O, Al-Balool H, Steyn J, Evans A, Colzani M . Circular RNA enrichment in platelets is a signature of transcriptome degradation. Blood. 2015; 127(9):e1-e11. PMC: 4797142. DOI: 10.1182/blood-2015-06-649434. View

11.

Wu Z, Sun H, Wang C, Liu W, Liu M, Zhu Y . Mitochondrial Genome-Derived circRNA mc-COX2 Functions as an Oncogene in Chronic Lymphocytic Leukemia. Mol Ther Nucleic Acids. 2020; 20:801-811. PMC: 7240210. DOI: 10.1016/j.omtn.2020.04.017. View

12.

Tan Y, Huang Z, Wang X, Dai H, Jiang G, Feng W . A novel fusion circular RNA F-circBA1 derived from the fusion gene displayed an oncogenic role in chronic myeloid leukemia cells. Bioengineered. 2021; 12(1):4816-4827. PMC: 8806869. DOI: 10.1080/21655979.2021.1957749. View

13.

Yokota T, Kanakura Y . Genetic abnormalities associated with acute lymphoblastic leukemia. Cancer Sci. 2016; 107(6):721-5. PMC: 4968601. DOI: 10.1111/cas.12927. View

14.

Juliusson G, Hough R . Leukemia. Prog Tumor Res. 2016; 43:87-100. DOI: 10.1159/000447076. View

15.

Chen L, Yang L . Regulation of circRNA biogenesis. RNA Biol. 2015; 12(4):381-8. PMC: 4615371. DOI: 10.1080/15476286.2015.1020271. View

16.

Pekarsky Y, Zanesi N, Croce C . Molecular basis of CLL. Semin Cancer Biol. 2010; 20(6):370-6. PMC: 2997849. DOI: 10.1016/j.semcancer.2010.09.003. View

17.

Hochhaus A, Baccarani M, Silver R, Schiffer C, Apperley J, Cervantes F . European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia. Leukemia. 2020; 34(4):966-984. PMC: 7214240. DOI: 10.1038/s41375-020-0776-2. View

18.

Deng W, Chao R, Zhu S . Emerging roles of circRNAs in leukemia and the clinical prospects: An update. Immun Inflamm Dis. 2023; 11(1):e725. PMC: 9801069. DOI: 10.1002/iid3.725. View

19.

Liu X, Liu X, Cai M, Luo A, He Y, Liu S . CircRNF220, not its linear cognate gene RNF220, regulates cell growth and is associated with relapse in pediatric acute myeloid leukemia. Mol Cancer. 2021; 20(1):139. PMC: 8549339. DOI: 10.1186/s12943-021-01395-7. View

20.

Zhong A, Yin Y, Tang B, Chen L, Shen H, Tan Z . CircRNA Microarray Profiling Reveals hsa_circ_0058493 as a Novel Biomarker for Imatinib-Resistant CML. Front Pharmacol. 2021; 12:728916. PMC: 8473700. DOI: 10.3389/fphar.2021.728916. View